Second blood clot case linked to Covid-19 vaccine reported in Australia

A 44-year-old male from Melbourne was diagnosed earlier this month as the first case with the blood clot syndrome.

A woman in Australia is in a stable condition and receiving treatment in hospital after she developed a blood clot syndrome following vaccination for Covid-19 with the AstraZeneca drug. File photo: Ayanda Ndamane/African News Agency (ANA)

CAPE TOWN, April 13 (ANA) – Australian health authorities announced on Tuesday that a second person had been diagnosed with rare blood clot syndrome after receiving the AstraZeneca Covid-19 vaccine.

According to The Guardian, the patient was a woman in her 40s from Western Australia who is in a stable condition and receiving treatment in hospital after developing the blood clot.

This comes after a 44-year-old male from Melbourne was diagnosed earlier this month as the first case with the syndrome.

The head of the Therapeutic Goods Administration (TGA) John Skerritt told reporters that the clotting and deep-vein thrombosis were extremely common and the administration used an “internationally accepted” method to link the case to the vaccine.

“There have been about 700,000 doses of AstraZeneca Covid-19 vaccine administered in Australia to date, so while numbers are small, two cases … equates to a frequency of 1 in 350,000,” Skerritt was quoted as saying.

“Your chances of winning the lotto are much higher.”

A statement posted on the department of health’s website said the TGA panel had concluded that the case was similar to those seen in Europe and the United Kingdom.

It said people should be aware of the common side effects of the Covid-19 vaccine including fever, sore muscles, tiredness and headaches which usually started within 24 hours of inoculation.

Australia Prime Minister Scott Morrison announced earlier this week that the country would drop its national vaccine rollout targets on advice from the Australian Technical Advisory Group on Immunisation.

Australia’s vaccination programme was initially based on the AstraZeneca vaccine, but due to complications it has joined several other countries in restricting its use.

The country has has administered more than 142,000 doses to aged care residents, with over 46,000 of these being second doses.

“While we would like to see these doses completed before the end of the year, it is not possible to set such targets given the many uncertainties involved,” Morrison said in a statement posted on his Facebook page.

“We will just get on with the job of working together to produce, distribute and administer the vaccines as safely and efficiently as possible.”

– African News Agency (ANA), Edited by Stella Mapenzauswa

ANA NEWS WIRE Disclaimer:
The African News Agency (ANA) is a news wire service and therefore subscribes to the highest standards of journalism as it relates to accuracy, fairness and impartiality.
ANA strives to provide accurate, well sourced and reliable information across Text, Images and Video. Where errors do appear, ANA will seek to correct these timeously and transparently.
The ANA platform also contains news and information from third party sources. ANA has sought to procure reliable content from trusted news sources but cannot be held responsible for the accuracy and opinions provided by such sources on the ANA platform or linked sites.
The content provided for on the ANA News Wire platform, both through the ANA news operation and via its third party sources, are for the sole use of authorised subscribers and partners. Unauthorised access to and usage of ANA content will be subject to legal steps. ANA reserves its rights in this regard.
ANA makes every effort to ensure that the website is up and running smoothly at all times, however ANA does not take responsibility for, and will not be held liable for times when the website is temporarily unavailable due to technical issues that are beyond our control.